NET PROFIT (x1000 SEK)
EMPLOYEES
Solural Pharma ApS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
9,064
|
4,078
|
503 |
Total assets |
19,492
|
12,596
|
9,279 |
Current assets |
17,890
|
11,313
|
8,692 |
Current liabilities |
4,579
|
2,862
|
2,573 |
Equity capital |
14,911
|
9,734
|
6,706 |
- share capital |
120
|
110
|
108 |
Employees (average) |
7
![]() |
7
![]() |
7 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
76.5%
|
77.3%
|
72.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
390.7%
|
395.3%
|
337.8% |
Return on equity (ROE) |
60.8%
|
41.9%
|
7.5% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.